U researchers orchestrate state’s fastest on-site testing for COVID-19
March 31, 2020
Related Stories
University of Minnesota expands clinical investigation of engineered iPSC-derived natural killer cells, opening U.S. clinical trial for the treatment of COVID-19
The engineered iPSC-derived natural killer (NK) cell product candidate, FT516, may help defeat the novel coronavirus.
https://twin-cities.umn.edu/news-events/university-minnesota-expands-clinical-investigation-engineered-ipsc-derived-natural
August 06, 2020
University of Minnesota, Twin Cities
08/06/2020
Research Brief: Official estimates of public health spending are significantly overinflated
The study was lead by JP Leider, a senior lecturer in the School of Public Health.
https://twin-cities.umn.edu/news-events/research-brief-official-estimates-public-health-spending-are-significantly-overinflated
July 28, 2020
University of Minnesota, Twin Cities
07/30/2020
Battling misinformation when health is at stake
PhD candidate Kristin Lunz Trujillo is confronting society's issues surrounding misinformation through her research.
https://twin-cities.umn.edu/news-events/battling-misinformation-when-health-stake
July 27, 2020
University of Minnesota, Twin Cities
07/28/2020
For early treatment of mild COVID-19, University of Minnesota trial shows hydroxychloroquine has no benefit over placebo
First randomized clinical trial of hydroxychloroquine to treat non-hospitalized adults with COVID-19
https://twin-cities.umn.edu/news-events/early-treatment-mild-covid-19-university-minnesota-trial-shows-hydroxychloroquine-has-no
July 16, 2020
University of Minnesota, Twin Cities
07/20/2020
https://twin-cities.umn.edu/node/381486
March 31, 2020
University of Minnesota, Twin Cities
05/20/2020
Share this article: